← Back to patent-cliff list
Lithium cocrystal
Tier C — Watch / tradeLithium cocrystal
University Of South Florida
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：Not applicable
Brand：LiProSal
Indications (approved)：Bipolar I disorder, Major depressive disorder, Mania, Post-traumatic stress disorder, Alzheimer's disease, Neurodegenerative disease, Depression
Regional status
US
Phase II
2022-05-04
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Lithium cocrystal?
Approved indications include: Bipolar I disorder, Major depressive disorder, Mania, Post-traumatic stress disorder, Alzheimer's disease, Neurodegenerative disease, Depression.
When does the Lithium cocrystal patent expire?
No public expiry year is available for Lithium cocrystal yet; this page updates once verified.
How do I get a quote for Lithium cocrystal intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-05